Pre-made Lampalizumab biosimilar ( Fab, anti-CFD therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-293
Anti-CFD therapeutic antibody (Pre-made Lampalizumab biosimilar,Fab) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D; it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-CFD therapeutic antibody (Pre-made Lampalizumab biosimilar,Fab)|
|Highest_Clin_Trial (Jan '20)||Phase-III|
|100% SI Structure||4d9q:HL:ED/4d9r:HL:ED|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Conditions Discontinued||Dry age-related macular degeneration|